Cargando…
Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy
With recent advances in oncology, immune checkpoint inhibitors (ICIs) have become a milestone in immuno-oncology. Unfortunately, although ICIs have demonstrated improved clinical efficacy in a broad spectrum of cancers, many patients do not respond to this newer therapy. As a result, it is crucial t...
Autores principales: | Parosanu, Andreea, Stanciu, Ioana Miruna, Pirlog, Cristina, Orlov Slavu, Cristina, Cotan, Horia, Iaciu, Cristian, Popa, Ana Maria, Olaru, Mihaela, Moldoveanu, Oana, Catalin, Baston, Nitipir, Cornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703028/ https://www.ncbi.nlm.nih.gov/pubmed/36451642 http://dx.doi.org/10.7759/cureus.30821 |
Ejemplares similares
-
The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Metastatic Renal Cell Carcinoma
por: Parosanu, Andreea Ioana, et al.
Publicado: (2023) -
Desensitization Protocol to Carboplatin: A Technical Report
por: Nitipir, Cornelia, et al.
Publicado: (2022) -
Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer—A Review of the Literature
por: Stanciu, Ioana-Miruna, et al.
Publicado: (2023) -
Correlation Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Programmed Death-Ligand 1 Expression as Prognostic Markers in Non-Small Cell Lung Cancer
por: Pirlog, Cristina-Florina, et al.
Publicado: (2022) -
Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature
por: Pîrlog, Cristina-Florina, et al.
Publicado: (2022)